Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Case Rep Oncol ; 15(1): 403-412, 2022.
Article in English | MEDLINE | ID: mdl-35702560

ABSTRACT

Primary sarcomas of the breast are heterogeneous neoplasms derived from the non-epithelial elements of the mammary gland. Malignant peripheral nerve sheath tumors comprise 5-10% of all malignant soft tissue sarcomas. Its heterogeneity and low incidence (1 in 100,000) limit the performance of prospective studies. Therefore, most published articles include individual reports and case series with a small number of patients, making it impossible to determine clear treatment standards in this scenario. A 36-year-old young woman with no personal history consulted the National Cancer Institute of Colombia with a 1-year progression of a rapidly growing mass in her left breast until reaching an approximate tumor size of 20 × 20 cm. Histopathological analysis with a tru-cut biopsy taken from the lesion revealed the presence of a breast sarcoma with positive staining for SOX-10 and S-100. A radical mastectomy as her first treatment included the resection of a costal arch and, therefore, the reconstruction of the chest wall with coverage of the defect with an extended latissimus dorsi flap followed by consolidation therapy with adjuvant radiotherapy (RT) and chemotherapy. Evidence regarding malignant peripheral nerve sheath sarcoma of the breast treatment corresponds to retrospective analyses and case reports with high heterogeneity and variability about strategies in surgical procedures and adjunctive therapy such as complementary chemotherapy and RT; therapeutic approach should always include a multidisciplinary team.

2.
Tumour Biol ; 41(5): 1010428319851014, 2019 May.
Article in English | MEDLINE | ID: mdl-31109257

ABSTRACT

Lung cancer has a high mortality rate in men and women worldwide. Approximately 15% of diagnosed patients with this type of cancer do not exceed the 5-year survival rate. Unfortunately, diagnosis is established in advanced stages, where other tissues or organs can be affected. In recent years, lineage-specific transcription factors have been associated with a variety of cancers. One such transcription factor possibly regulating cancer is RUNX2, the master gene of early and late osteogenesis. In thyroid and prostate cancer, it has been reported that RUNX2 regulates expression of genes important in tumor cell migration and invasion. In this study, we report on RUNX2/ p57 overexpression in 16 patients with primary non-small cell lung cancer and/or metastatic lung cancer associated with H3K27Ac at P1 gene promoter region. In some patients, H3K4Me3 enrichment was also detected, in addition to WDR5, MLL2, MLL4, and UTX enzyme recruitment, members of the COMPASS-LIKE complex. Moreover, transforming growth factor-ß induced RUNX2/ p57 overexpression and specific RUNX2 knockdown supported a role for RUNX2 in epithelial mesenchymal transition, which was demonstrated through loss of function assays in adenocarcinoma A549 lung cancer cell line. Furthermore, RUNX2 increased expression of epithelial mesenchymal transition genes VIMENTIN, TWIST1, and SNAIL1, which reflected increased migratory capacity in lung adenocarcinoma cells.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Non-Small-Cell Lung/secondary , Core Binding Factor Alpha 1 Subunit/metabolism , Epigenesis, Genetic , Epithelial-Mesenchymal Transition , Lung Neoplasms/pathology , Promoter Regions, Genetic , Adult , Aged , Aged, 80 and over , Apoptosis , Biomarkers, Tumor/genetics , Carcinoma, Non-Small-Cell Lung/genetics , Carcinoma, Non-Small-Cell Lung/metabolism , Case-Control Studies , Cell Movement , Cell Proliferation , Core Binding Factor Alpha 1 Subunit/genetics , Female , Follow-Up Studies , Gene Expression Regulation, Neoplastic , Humans , Lung Neoplasms/genetics , Lung Neoplasms/metabolism , Male , Middle Aged , Neoplasm Invasiveness , Prognosis , Tumor Cells, Cultured
3.
Acta méd. colomb ; 40(4): 338-344, oct.-dic. 2015. ilus, tab
Article in Spanish | LILACS, COLNAL | ID: biblio-949485

ABSTRACT

La neurotoxicidad de los medicamentos antineoplásicos es un fenómeno de relativa frecuencia, que ocurre principalmente sobre el sistema nervioso periférico y más comúnmente con fármacos citotóxicos como platinos, taxanos y derivados de la vinca. La toxicidad sobre el sistema nervioso central asociado al uso del 5-fluorouracilo es por el contrario un evento poco común, pero no por ello menos importante. El clínico debe aprender a reconocer y tratar las dos variedades de esta condición médica: la encefalopatía aguda y la leucoencefalopatía subaguda; cada una con fisiopatología, manifestaciones clínicas y tratamiento diferentes. La siguiente presentación de casos ejemplifica estas dos variedades y brinda elementos diagnósticos y terapéuticos para cada una de ellas. (ActaMed Colomb 2015; 40: 338-344).


The neurotoxicity of anticancer drugs is a relatively common phenomenon, occurring mainly on the peripheral nervous system, most commonly with cytotoxic drugs such as platinum, taxanes and vinca derivatives. Toxicity on the central nervous system associated with the use of 5-fluorouracil is on the contrary a rare event, which does not make it less important. The clinician must learn to recognize and treat the two varieties of this medical condition: acute encephalopathy and sub-acute leukoencephalopathy, each with different pathophysiology, clinical manifestations and treatment. The following case presentation illustrates these two varieties and provides diagnostic and therapeutic elements for each one of them. (Acta Med Colomb 2015; 40: 338-344).


Subject(s)
Humans , Female , Middle Aged , Brain Diseases , Thiamine Deficiency , Hyperammonemia , Toxicity , Leukoencephalopathies , Fluorouracil
SELECTION OF CITATIONS
SEARCH DETAIL
...